Anadrol vs Ara 290
FDA Approved vs Extensively Studied
monitor Mechanism-based · 65% Both Anadrol and Ara 290 can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%.
Molecular Data
Anadrol Ara 290
Weight 332.48 Da 1,257 Da
Half-life ~8-9 hours ~20 minutes (SubQ), ~2 minutes (IV)
Chain — 11 amino acids
Type 17-alpha alkylated anabolic steroid (C21H32O3) Engineered peptide
Key Benefits
Anadrol
01 Rapid and dramatic increases in muscle mass and bodyweight
02 Exceptional strength gains, often noticeable within the first week
03 Potent stimulation of erythropoietin and red blood cell production
04 Increased appetite and nutrient partitioning in some users
05 Improved recovery between training sessions
06 Full, round muscle appearance due to intramuscular water and glycogen retention
07 FDA-approved treatment for various forms of anemia
Ara 290
01 Proven tissue protection
02 Nerve regeneration
03 Anti-inflammatory effects
04 Excellent safety profile in clinical trials
Dosing Protocols
Anadrol
25-50 mg/day / Once or twice daily (oral)
Ara 290
4 mg daily / Once daily
Neuropathy Treatment 4 mg daily Once daily
Tissue Protection 1-8 mg daily Once daily
Acute Intervention 2 mg 3x weekly
Side Effects
Anadrol
Significant water retention and bloating (estrogenic, not aromatase-mediated)
Elevated blood pressure (fluid volume and RBC increase)
Severe liver stress and elevated liver enzymes (AST/ALT)
Back pumps and lower back pain during exercise
Headaches (often blood pressure-related)
Appetite suppression (paradoxical for a mass-building compound)
Lethargy and fatigue (hepatic strain-related)
Acne and oily skin
Suppression of natural testosterone production
Ara 290
Excellent safety profile in clinical trials with no serious drug-related adverse events
Contraindications
Pre-existing liver disease or significantly elevated liver enzymes
Prostate cancer or breast cancer in males
Nephrotic phase of nephritis
Hypercalcemia (Anadrol can exacerbate calcium levels)
Pregnancy (Category X - causes virilization of the female fetus)
Known hypersensitivity to oxymetholone
Concurrent use of other 17-alpha alkylated oral steroids (compounded liver toxicity)
Recent anti-TNF therapy (within 6 months)
EPO use (within 2 months)
Pregnancy
BMI > 34 kg/m²
Research Evidence
Anadrol Ara 290
Status FDA Approved Extensively Studied
References 5 studies 5 studies
Latest 2018 2024
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.